poisar

Stocks · News reference

Lipocine Inc. Reports Third Quarter 2026 Financial Results

Fiscal.ai

Lipocine Inc. announced its financial results for the third quarter ended September 30, 2026, reporting a net loss of $0.7 million and total revenue of $2.3 million.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Lipocine Inc. (LPCN)

    Filed: 2026-11-10 AccNo: 0001493152-26-050842 Size: 239 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits